Our mission is to discover and develop innovative therapies to transform the lives of people with rare central nervous system disorders. Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Lysogene’s determination to advance scientific discovery and improve lives is guided by core principles and values shared by our entire team. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers.
This company is:
Verified
Awesome & Co – Lysogene
SAXA | UI/UX & Art Direction | Client | Year | Services | A bit of history | Applied methods
Verified
Web Design – Lysogene
Web Design | The Monster | Issa Glasses | Box Food | Untold Secret | Nike | Pharrell Williams | Mo-op drinks
Verified
The Monster – Lysogene
The Monster | Client | Year | Designer | Details | Services | The Monster was an interesting project because is a UX designer based in London. | Background | Project Details
View all products
Keywords
Industries
Where is LYSOGENE located?
The company LYSOGENE is located in Neuilly-sur-Seine, Ile-de-France, France. It's worth noting that the company may has more corporate locations
How many employees does LYSOGENE approximately have?
As of the latest available information LYSOGENE has around 11-50 employees worldwide.
When was LYSOGENE founded?
LYSOGENE was founded in 2009
In which industries does LYSOGENE mainly work?
The company LYSOGENE has it's main focus in the industries of Biotechnology
Lysosomal and Rare Disorders Research and Treatment Center (LDRTC)
United States
11-50 Employees
2013
View
Genoscience Pharma
France
11-50 Employees
2001
View
Neurogene
United States
11-50 Employees
2018
View
Lgenia
United States
11-50 Employees
2018
View
LEXEO Therapeutics
United States
11-50 Employees
2018
View
Sio Gene Therapies
United States
101-250 Employees
2014
View
Amicus Therapeutics
United States
501-1000 Employees
2002
View
StrideBio
United States
51-100 Employees
2015
View
Topics which have been searched by others and may be interesting for you: